Somatic mutations in chromatin remodeler genes could modify the epigenomic landscape of CLL, but These are unheard of In this particular malignancy compared to other lymphoid neoplasms. CHD2 See "Targeted therapies in CLL: mechanisms of resistance and methods for management" on web page 471. System kami juga kompatibel dengan desktop https://nathaniela864raj1.elbloglibre.com/profile